1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. AXSOME THERAPEUTICS INC
Axsome Therapeutics Inc XNAS: AXSM

Axsome Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Momentum Trap
about

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline product...

Read More
121.75 -0.11 (-0.09%)
61.13% Gain from 52W Low
369.7K
XNAS Volume

XNAS 28 Aug, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
22.2 / 100
Valuation Score
Expensive Valuation
6.5 / 100
Momentum Score
Technically Moderately Bullish
61.8 / 100
Momentum Trap These stocks are with a bad quality and poor financial score ranging from medium to expensive valuation. Rising technical aspects may attract investors, but, weak financials cannot be overlooked. View Similar Embed DVM
Analyst Price Target
177
1Yr Price target upside is 45%
19 analysts

17

S

10

W

4

O

1

T

SWOT Analysis

Axsome Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..